| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/19/2006 | CA2572467A1 Vector packaging cell line |
| 01/19/2006 | CA2571130A1 P75ntr screening assay for indentifying modulators of apoptosis |
| 01/19/2006 | CA2570298A1 Polynucleotides encoding mature ahasl proteins for creating imidazolinone-tolerant plants |
| 01/19/2006 | CA2554419A1 Altering root structure during plant development |
| 01/19/2006 | CA2544692A1 Anti-glypican 3 antibody |
| 01/18/2006 | EP1617219A1 Element having bioactive substance fixed thereto |
| 01/18/2006 | EP1617217A1 Organic substance immobilizing chip and its use |
| 01/18/2006 | EP1616967A2 Primers for isothermal amplification and genotyping of Hepatitis C virus |
| 01/18/2006 | EP1616966A2 Enhancement of alkaline phosphatase with SDS in chemiluminescent substrates and enzyme inhibition assays |
| 01/18/2006 | EP1616964A2 Process for preparative in vitro protein biosynthesis |
| 01/18/2006 | EP1616963A2 Process for producing dipeptides or dipeptide derivatives |
| 01/18/2006 | EP1616961A1 Vectors and methods for gene transfer to cells |
| 01/18/2006 | EP1616960A2 Human pancreatic cell lines: developments and uses |
| 01/18/2006 | EP1616959A1 Biological safe transient protein expression in plants |
| 01/18/2006 | EP1616958A2 Notch-ligands for use in immunotherapy |
| 01/18/2006 | EP1616957A1 Vector |
| 01/18/2006 | EP1616955A1 Catalyst for sugar chain cleavage |
| 01/18/2006 | EP1616954A2 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 01/18/2006 | EP1616953A1 Method of detecting beta 3 adrenaline receptor mutant gene and nucleic acid probe and kit therefor |
| 01/18/2006 | EP1616952A1 Method of detecting pancryatic islet amyloid protein mutant gene and nucleic acid probe and kit therefor |
| 01/18/2006 | EP1616951A1 Method of isolating nucleic acid and, for nucleic acid isolation, kit and apparatus |
| 01/18/2006 | EP1616949A1 Novel vector and method of constructing transformant plant using the vector |
| 01/18/2006 | EP1616947A1 METHOD OF SYNTHESIZING cDNA |
| 01/18/2006 | EP1616946A1 Process for producing D-N-carbamoyl-alpha-amino acids |
| 01/18/2006 | EP1616945A1 Process for producing D-N-carbamoyl-alpha-amino acids |
| 01/18/2006 | EP1616943A1 Avian primordial germ cell (PGC) cell line and a method for long term culturing thereof |
| 01/18/2006 | EP1616942A2 Patched genes and their use |
| 01/18/2006 | EP1616885A1 Recombinant antibody recognizing dioxin and gene encoding the antibody |
| 01/18/2006 | EP1616884A2 Zcytor7 cytokine receptor and antibody thereto |
| 01/18/2006 | EP1616883A2 Antibodies against VLA-4 |
| 01/18/2006 | EP1616882A2 Apo-2 receptor antibodies |
| 01/18/2006 | EP1616881A1 Anti-mpl antibodies |
| 01/18/2006 | EP1616879A2 Human cub-domain-containing protein and gene encoding the same |
| 01/18/2006 | EP1616878A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/18/2006 | EP1616876A2 A method for identification, isolation and production of antigens to a specific pathogen |
| 01/18/2006 | EP1616875A1 GD3-mimetic peptides |
| 01/18/2006 | EP1616620A2 Method for coating particles |
| 01/18/2006 | EP1616580A2 Alpha-amylase transcription factor |
| 01/18/2006 | EP1616579A1 CD40 binding molecules and CTL peptides for treating tumors |
| 01/18/2006 | EP1616578A1 Compositions and methods for delivery of genetic material |
| 01/18/2006 | EP1616575A1 Method for treating inflammation |
| 01/18/2006 | EP1616183A2 Methods of detecting neurological disorders |
| 01/18/2006 | EP1616033A2 Dna polymerase fusions and uses thereof |
| 01/18/2006 | EP1616015A2 Methods and compositions to increase plant resistance to stress |
| 01/18/2006 | EP1616014A2 Method to increase stress tolerance in plants |
| 01/18/2006 | EP1616013A2 Methods and means for increasing the tolerance of plants to stress conditions |
| 01/18/2006 | EP1616012A2 Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof |
| 01/18/2006 | EP1616011A2 Chimeric polypeptides and their use |
| 01/18/2006 | EP1616010A2 Cytokine polypeptides and antibodies containing a signal sequence for the attachment of glycosylphosphatidylinositol |
| 01/18/2006 | EP1616009A2 Method for treatment of angiogenic disorders |
| 01/18/2006 | EP1616008A2 Ligation-based synthesis of oligonucleotides with block structure |
| 01/18/2006 | EP1616007A1 Inhibitor proteins of a protease and use thereof |
| 01/18/2006 | EP1616004A1 Process for isolating and purifing ovine hyaluronidase |
| 01/18/2006 | EP1616002A2 Method for obtaining mastocyte lines from porcine tissue and method for production of heparin type molecules |
| 01/18/2006 | EP1616001A1 Method for improving germline transmission efficiency of avian primordial germ cells |
| 01/18/2006 | EP1615998A2 Plant cells and plants with increased tolerance to environmental stress |
| 01/18/2006 | EP1615996A2 Uses of vascular endothelial growth factor and type i collagen inducible protein (vcip) |
| 01/18/2006 | EP1615995A2 Morpholino imaging and therapy via amplification targeting |
| 01/18/2006 | EP1615988A2 Highly controllable electroporation and applications thereof |
| 01/18/2006 | EP1615953A2 Agent comprising an albumin-like first polypeptide bound to a second polypeptide |
| 01/18/2006 | EP1615952A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
| 01/18/2006 | EP1615943A2 Compositions and methods for sirna inhibition of angiopoietin 1 and 2 and their receptor tie2 |
| 01/18/2006 | EP1615942A2 Polymerase inhibitor and method of using same |
| 01/18/2006 | EP1615670A2 Targets for tumor growth inhibition |
| 01/18/2006 | EP1615663A1 Agent for treating leishmania infections |
| 01/18/2006 | EP1615658A1 Inhibition of tumor cell proliferation by foxm1b inhibitors |
| 01/18/2006 | EP1615611A2 iRNA CONJUGATES |
| 01/18/2006 | EP1615494A1 Non-human mammals and animal cells containing a mutated alpha2/delta gene |
| 01/18/2006 | EP1615493A2 Non-human mammals and animal cells containing a mutated alpha2/delta1 gene |
| 01/18/2006 | EP1615492A2 Methods for correcting mitotic spindle defects associated with somatic cell nuclear transfer in animals |
| 01/18/2006 | EP1615491A2 Improved plant transformation |
| 01/18/2006 | EP1539816B1 Thrombin-cleavable factor x analogues |
| 01/18/2006 | EP1487968A4 Methods of inducing differentiation of stem cells into a specific cell lineage |
| 01/18/2006 | EP1409741B1 Detection method of nucleic acid hybridization |
| 01/18/2006 | EP1395675B1 A method for measuring dna polymerization and applications of the method |
| 01/18/2006 | EP1337325B1 Acoustic ejection of fluids from a plurality of reservoirs |
| 01/18/2006 | EP1307214A4 Highly homogeneous molecular markers for electrophoresis |
| 01/18/2006 | EP1278851B1 Humanised antibodies to the epidermal growth factor receptor |
| 01/18/2006 | EP1232282B8 Automated method for identifying related biomolecular sequences |
| 01/18/2006 | EP1207958B8 Sensor for microfluid handling system |
| 01/18/2006 | EP1127068B1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 01/18/2006 | EP1124990B1 Complexity management and analysis of genomic dna |
| 01/18/2006 | EP1100925B1 Attenuated equine herpesvirus |
| 01/18/2006 | EP1038010B1 Gram-positive microorganism formate transporters |
| 01/18/2006 | EP0942917A4 Stable compositions for nucleic acid amplification and sequencing |
| 01/18/2006 | EP0915910B1 Exendin analogues, processes for their preparation and medicaments containing them |
| 01/18/2006 | EP0904101B1 Nucleic acids encoding gdp-fucose pyrophosphorylase |
| 01/18/2006 | EP0882129B1 Recombinant expression of s-layer proteins |
| 01/18/2006 | EP0782630B1 Polycystic kidney disease gene |
| 01/18/2006 | CN1723391A Oligopeptides for promoting hair growth |
| 01/18/2006 | CN1723286A Method for the biotechnological production of citric acid by means of a genetically-modified yeast yarrowia lipolytica |
| 01/18/2006 | CN1723285A Recombinant MVA and method for generation thereof |
| 01/18/2006 | CN1723284A Regulatory zinc finger proteins |
| 01/18/2006 | CN1723283A Method for manufacturing recombinant polyclonal proteins |
| 01/18/2006 | CN1723282A Protein complex, process for producing the same and use thereof |
| 01/18/2006 | CN1723281A Mutated d-aminotransferase and method for producing optically active glutamic acid derivatives using the same |
| 01/18/2006 | CN1723280A Gene improving temperature-tolerance of acetic acid bacterium, acetic acid bacterium bred using the gene and process for producing vinegar using the acetic acid bacterium |
| 01/18/2006 | CN1723278A Radio link protocol sync procedure |
| 01/18/2006 | CN1723220A A pharmaceutical composition comprising an immunoglobulin FC region as a carrier |
| 01/18/2006 | CN1723219A Protein complex using immunoglobulin fragment andmethod for the preparation thereof |